Donepezil reduces the time caregivers spend providing care: Results of a one-year, double-blind randomized trial in patients with mild to moderate Alzheimer's disease.

被引：0

作者：

Mastey, V

Wimo, A

Winblad, B

Haglund, A

Jacobson, L

Miceli, R

Zhang, R

Subbiah, P

机构：

[1] Pfizer Inc, Pfizer Pharmaceut Grp, New York, NY USA

[2] Umea Univ, Dept Family Med, Umea, Sweden

[3] Karolinska Inst, Huddinge, Sweden

[4] Pfizer AB, Taby, Sweden

来源：

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2001年 / 49卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

P16

引用

页码：S20 / S20

页数：1

共 50 条

[31] A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease
Shahin Akhondzadeh
Mehdi Shafiee Sabet
Mohammad Hossein Harirchian
Mansoreh Togha
Hamed Cheraghmakani
Soodeh Razeghi
Seyyed Shamssedin Hejazi
Mohammad Hossein Yousefi
Roozbeh Alimardani
Amirhossein Jamshidi
Shams-Ali Rezazadeh
Aboulghasem Yousefi
Farhad Zare
Atbin Moradi
Ardalan Vossoughi
Psychopharmacology, 2010, 207 : 637 - 643
[32] Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease:: a double blind, randomized and placebo-controlled trial
Akhondzadeh, S
Noroozian, M
Mohammadi, M
Ohadinia, S
Jamshidi, AH
Khani, M
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (01) : 53 - 59
[33] Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: Results from a 24-week, double-blind, placebo-controlled, Randomized trial
Homma, Akira
Imai, Yukimichi
Tago, Hisao
Asada, Takashi
Shigeta, Masahiro
Iwamoto, Toshihiko
Takita, Masashi
Arimoto, Itaru
Koma, Hiroshi
Ohbayashi, Toshio
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (05) : 399 - 407
[34] Donepezil treatment of severe Alzheimer's disease: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
Black, S.
Li, H.
McRae, T.
Richardson, S.
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 69 - 69
[35] Treatment of severe Alzheimer's disease with donepezil: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
Black, S
Li, HL
McRae, T
Richardson, S
NEUROLOGY, 2006, 66 (05) : A347 - A347
[36] Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer’s DiseasePost Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
Stephen Aronson
Bart Van Baelen
Shane Kavanagh
Susanne Schwalen
Drugs & Aging, 2009, 26 : 231 - 239
[37] A Double-Blind Placebo-Controlled Randomized Trial of Melissa officinalis Oil and Donepezil for the Treatment of Agitation in Alzheimer's Disease
Burns, Alistair
Perry, Elaine
Holmes, Clive
Francis, Paul
Morris, Julie
Howes, Melanie-Jayne R.
Chazot, Paul
Lees, George
Ballard, Clive
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (02) : 158 - 164
[38] A Phase III, Placebo-Controlled, Double-Blind, Randomized Trial of Tramiprosate in the Clinical Management of Patients with Mild-to-Moderate Alzheimer's Disease (the Alphase Study)
Aisen, Paul
Gauthier, Serge
Ferris, Steven
Garceau, Denis
Saumier, Daniel
Duong, Anh
Sampalis, John
NEUROLOGY, 2009, 72 (11) : A271 - A271
[39] A one-year, randomized, placebo-controlled, double-blind trial of rosiglitazone in non alcoholic steatohepatitis: Results of the FLIRT pilot trial
Ratziu, V.
Jacqueminet, S.
Giral, P.
Podevin, P.
Serfaty, L.
Charlotte, F.
Bruckert, E.
Bernhardt, C.
Grimaldi, A.
Poynard, T.
DIABETOLOGIA, 2006, 49 : 704 - 705
[40] A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease
Brody, Mark
Liu, Enchi
Di, Jianing
Lu, Ming
Margolin, Richard A.
Werth, John L.
Booth, Kevin
Shadman, Anna
Brashear, H. Robert
Novak, Gerald
JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (04) : 1509 - 1519

← 1 2 3 4 5 →